Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Disclosure of total number of voting rights and number of shares in the capital at September 30, 2026
-
WUBEN Prime Day 2026 Offers Exclusive Rewards
-
Resolution Therapeutics to present interim Phase I/II EMERALD study data on RTX001 as a late-breaker at AASLD 2026
-
Optimum Strategic Communications to Host 18th Annual Healthcare Investor Conference
-
Caseware Verity-Powered Risk Suggestion Agent Launches to Help Auditors Identify Engagement-Specific Risks
-
PropLaunch Joins Forces with Axcera and RUBIK to Help Founders Launch Prop Firms
-
CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES
-
Xometry Names Marc Teulières as General Manager for Europe to Accelerate Regional Adoption
-
HI-VIEW RESOURCES COMPLETES 2026 EXPLORATION FIELD PROGRAM IN THE TOODOGGONE MINING DISTRICT, BRITISH COLUMBIA
-
Canada’s project boom could generate $443B in revenues for SMEs: BDC study
-
RougeTx Launches with $58 Million Series A Financing to Advance First-in-Class Treatment for Hereditary Hemorrhagic Telangiectasia
-
Rewind Therapeutics Secures Additional Financing to Advance Oral GPR17 Remyelination Program
-
Jeppesen ForeFlight Airflow™ Agents Debut for Commercial Aviation, Centered on Operating Intelligence and Adoption Flexibility
-
Angelini Ventures and EIB Co-lead $58 Million Series A Financing in Rouge Therapeutics to Advance First-in-Class Treatment for Hereditary Hemorrhagic Telangiectasia
-
RQ Bio Appoints Gavin Koh as Chief Medical Officer and Strengthens Leadership to Advance RQB01
-
One04 Therapeutics to present late-breaking interim Phase 1 results for CPV-104 in C3 glomerulopathy at ASN Kidney Week followed by Virtual KOL Event
-
One04 Therapeutics to present late-breaking interim Phase 1 results for CPV-104 in C3 glomerulopathy at ASN Kidney Week followed by Virtual KOL Event
-
Gabriel Holding A/S upwardly adjusts its expectations for the financial year 2025/26 for the continuing operations.
-
Verdora Excellence Alliance Expands Intelligent Capital and Risk Management Framework
-
New Beauty Platform GlowEra Launches to Help Women Look Their Best Without Expensive Procedures
-
LUBIS EDA Launches FormalOS: Infrastructure for Systematic, Scalable Formal Verification
-
KVB Accelerates Middle East Footprint with Strategic MENA Regional Expansion
-
LG U+ selects the Digital Vending Machine® from Bango to expand its subscription bundling
-
Equinor ASA: Share buy-back – third tranche for 2026
-
Statement regarding possible offer
-
Production update and FTSE 250 Index inclusion
-
NBPE Announces Transaction in Own Shares
-
Transaction in Own Shares
-
Progress on share buyback programme
-
Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European market
-
Bulk Peptides: Kylo Peptides Launches Bulk Research Program for High-Volume Laboratories
-
Sender registration lifts Lleida.net's SMS traffic towards Spain operators by 40%
-
Kylo Peptides Review Brings Transparency to the Research Peptide Market
-
Bpce: BPCE and Banco Sabadell announce BPCE’s friendly acquisition of a participation in Banco Sabadell and their intention to explore strategic cooperation
-
Press Release : Availability of the aide-mémoire for Q3 2026 results
-
Nox Peptides Announces Expanded Research Focus on BPC-157 as Canadian Peptide Research Supply Demand Grows
-
Trifork strengthens focus on the public sector with new Vice President
-
Peptides Canada Operated by Growth Guys Announces Launch of Domestic Research Peptide Supply Platform
-
TextMagic group’s sales results for Q3 2026
-
Start of Day Message
-
Trifork Group strengthens Executive Management with Group COO role
-
ALSTOM S.A: Aide-memoire ahead of H1 2026/27 publication
-
AB Tewox has fully redeemed its EUR 35 million bond issue (ISIN LT0000409567)
-
Lerøy Seafood Group ASA: Q3 2026 Volume Update
-
Global Capital Meets Frontier Technology at Digital Assets & Tokenization Summit in Singapore
-
Global Capital Meets Frontier Technology at Digital Assets & Tokenization Summit in Singapore
-
Independent study strengthens Amargosa’s road-to-port export chain, supporting haulage rates up to 11.5 Mtpa
-
YSX TECH. CO. LTD to Hold Extraordinary General Meeting of Shareholders
-
Blaize Provides Preliminary Third Quarter 2026 Revenue Update and Full-Year Guidance Update
-
Spyre Therapeutics Announces Pricing of $350.0 Million Public Offering of Common Stock
